scispace - formally typeset
Open AccessJournal ArticleDOI

The Significance of OX40 and OX40L to T cell Biology and Immune Disease

Reads0
Chats0
TLDR
This review provides a broad overview of the biology of OX40 including the intracellular signals from OX 40 that impact many aspects of immune function and have promoted Ox40 as one of the most prominent costimulatory molecules known to control T cells.
Abstract
OX40 (CD134) and its binding partner, OX40L (CD252), are members of the TNFR/TNF superfamily and are expressed on activated CD4 and CD8 T cells as well as a number of other lymphoid and non-lymphoid cells. Costimulatory signals from OX40 to a conventional T cell promote division and survival, augmenting the clonal expansion of effector and memory populations as they are being generated to antigen. OX40 additionally suppresses the differentiation and activity of Treg, further amplifying this process. OX40 and OX40L also regulate cytokine production from T cells, antigen-presenting cells, NK cells, and NKT cells, and modulate cytokine receptor signaling. In line with these important modulatory functions, OX40/OX40L interactions have been found to play a central role in the development of multiple inflammatory and autoimmune diseases, making them attractive candidates for intervention in the clinic. Conversely, stimulating OX40 has shown it to be a candidate for therapeutic immunization strategies for cancer and infectious disease. This review provides a broad overview of the biology of OX40, and the intracellular signals from OX40, that impact many aspects of immune function, and have promoted OX40 as one of the most prominent costimulatory molecules known to control T cells.

read more

Citations
More filters
Journal ArticleDOI

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

TL;DR: The results demonstrate that excessive non-effective host immune responses by pathogenic T cells and inflammatory monocytes may associate with severe lung pathology and suggest that monoclonal antibodies targeting GM-CSF or interleukin 6 may be effective in blocking inflammatory storms and, therefore, be a promising treatment of severe COVID-19 patients.
Journal ArticleDOI

Systemic lupus erythematosus.

TL;DR: This Seminar reflects on changes in systemic lupus erythematosus classification criteria; considers aspects of its more serious clinical expression; and provides a brief review of its aetiopathogenesis, major complications, coping strategies, and conventional treatment.
Journal ArticleDOI

COVID-19: immunopathogenesis and Immunotherapeutics.

TL;DR: The immunopathology of COVID-19 is discussed, its potential mechanisms, and clinical implications to aid the development of new therapeutic strategies against COIDs, which includes enhancing anti-viral immunity while inhibiting systemic inflammation.
Book ChapterDOI

Endothelial Dysfunction and Hypertension.

TL;DR: The aim of this chapter is to explain endothelial dysfunction and the circulating molecules of endothelial cells as they become potential targets of therapeutic approach for hypertension, and the role of endothelium dysfunction in white coat hypertension has been discussed.
Journal ArticleDOI

Mechanisms of costimulation.

TL;DR: In this article, the authors provide perspectives on key functions of costimulatory pathways, highlighting recent advances, and discuss how this progress is changing our view of the functions of T-cell costimulation.
References
More filters
Journal ArticleDOI

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

TL;DR: It is shown that expression of CCR7, a chemokine receptor that controls homing to secondary lymphoid organs, divides human memory T cells into two functionally distinct subsets, which are named central memory (TCM) and effector memory (TEM).
Journal ArticleDOI

Regulatory T Cells and Immune Tolerance

TL;DR: The cellular and molecular basis of Treg development and function is revealed and dysregulation of T Regs in immunological disease is implicates.
Journal ArticleDOI

A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

TL;DR: It is shown that chronic activation of both human and murine CD4+T cells in the presence of interleukin (IL)-10 gives rise to CD4-T-cell clones with low proliferative capacity, producing high levels ofIL-10, low levels of IL-2 and no IL-4.
Journal ArticleDOI

CTLA-4 Control over Foxp3+ Regulatory T Cell Function

TL;DR: It is shown that a specific deficiency of cytotoxic T lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneous development of systemic lymphoproliferation, fatal T cell–mediated autoimmune disease, and hyperproduction of immunoglobulin E in mice.
Journal ArticleDOI

NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase

TL;DR: It is shown that the Akt serine–threonine kinase is involved in the activation of NF-κB by tumour necrosis factor (TNF), and that Akt is part of a signalling pathway that is necessary for inducing key immune and inflammatory responses.
Related Papers (5)